After two days of exploding pagers and walkie-talkies, Beirut was a city on edge, with people worried there were bombs in their bags or pockets. Victims’ relatives vowed retribution. By Hwaida ...

Rayne Beau, a lost cat, managed to travel 800 miles back home after vanishing during a camping trip in Yellowstone National Park. Found exhausted in Roseville, California, he was reunited with his ...

Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in ...

Concomitant Lewy body pathology exacerbated cognitive decline in Alzheimer's disease. (Nature Communications) Blocking ...

The following is a summary of “Changes in use of migraine medications, healthcare resource utilization, and associated direct costs over 12 Months following initiation of Erenumab: A US retrospective ...

Erenumab effectively induces Medication Overuse Headache remission in chronic migraine patients. Monthly 140 mg injections ...

Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine (CM) and MOH, according to a ...

Aimovig (erenumab-aooe) is a brand-name subcutaneous injection that’s prescribed to help prevent migraine headaches in adults. As with other drugs, Aimovig can cause side effects, such as ...

Studies show that by reducing CGRP activity, we can reduce migraine frequency.” Erenumab is unique among these as it is the only injectable that binds to the CGRP receptor, or “sits where CGRP ...

In this study, monthly, 140 mg erenumab injections safely and effectively achieved medication overuse headaches remission in patients ...

In this study, monthly, 140 mg erenumab injections safely and effectively achieved medication overuse headaches remission in patients with nonopioid chronic migraine and medication overuse headaches ...

Erenumab - also known by the name Aimovig - is one of the first bespoke migraine drugs in decades and has been described by doctors as a "huge deal". But the body that approves new drugs said ...